In Other News

• Researchers Develop Cheaper, Rapid, and Accurate Pooling Strategy for RT-PCR-Based Detection of SARS-CoV-2

• Diazyme Partners with Maccura Biotechnology to Launch FDA EUA Approved SARS-CoV-2 RT-PCR Diagnostics Test

• US FDA Authorizes First Tests from Siemens That Estimate Antibodies from Past COVID-19 Infections

• New Rapid Test Determines Amount of Neutralizing Antibodies Against SARS-CoV-2 Within Short Period of Time

• US COVID-19 Testing Supply Data Reveal One Million Tests Being Shipped Per Day

• Carolina Liquid Chemistries Secures FDA Emergency Use Authorization for COVID-19 Test Kits

• Seegene Allplex 2019-nCoV Assay (SARS-CoV-2) Granted Expanded FDA Emergency Use Authorization

• Sorrento Therapeutics to Market Columbia University’s Rapid On-Site Detection Test for SARS-CoV-2 Virus in Saliva

• AACC Survey Finds Nearly Half of All US Labs Still Do Not Have Supplies for Running COVID-19 Tests

• Truvian Sciences’ Easy Check COVID-19 IgM/IgG Test Receives FDA Emergency Use Authorization

• Ultrasensitive Droplet Biosensing Method Dramatically Shortens Identification Time for COVID-19

• First-of-Its-Kind Rapid COVID-19 Test Detects Neutralizing Antibodies with 99-100% Specificity and 95-100% Sensitivity Within an Hour

• Bruker Launches Second-Generation FluoroType SARS-CoV-2 Plus PCR Test

• Roche to Launch New SARS-CoV-2 Tests and Begin Conducting Research on Potential COVID-19 Drug

• Sputum Testing Has Significantly Higher COVID-19 Detection Rate than Oropharyngeal Swab Testing

• US National COVID-19 Diagnostic Supply Registry Launched to Provide Updates on Molecular, Antigen and Serology Tests Shipments

• HHS National COVID-19 Testing Implementation Forum to Improve Collaboration in Advancement of Innovation in SARS-CoV-2 Testing

• Global COVID-19 Diagnostics and Therapy Market Projected to Reach USD 13.9 Billion in 2025

• PerkinElmer Launches New Dried Blood Spot Based COVID-19 Serology Test

• COVID-19 Patients with Lymphocytopenia Are Likely to Suffer Severe Disease Symptoms

• Quidel’s Sofia SARS Antigen FIA Updates EUA Performance Data to 96.7% PPA Versus PCR

• Luminex COVID-19 Antibody Test Receives FDA Emergency Use Authorization

• Study Finds Significant Variability in Accuracy of Marketed COVID-19 Antibody Tests